Juno Biomedical
Juno Biomedical, Inc. is a pioneering medical device company based in Ontario, CA, dedicated to advancing neurological repair and personalized medicine. Their patented technology, CELLTech Stroke, aims to improve motor function in patients with permanent, moderate to severe disability caused by subcortical ischemic stroke. CELLTech utilizes a deep brain stimulation system that applies microcurrents directly to brain tissue, with the goal of regrowing damaged tissues post-stroke and restoring the quality of life for stroke survivors.
With a team of renowned physicians and extensive collaboration with the FDA, Juno Biomedical is committed to ensuring the safety and effectiveness of CELLTech for human use. Their innovative approach to stroke treatment holds the potential to reverse or modify deficits caused by strokes, offering hope and brighter futures for countless individuals worldwide.
Generated from the website